1. Home
  2. WDI vs ZVRA Comparison

WDI vs ZVRA Comparison

Compare WDI & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Diversified Income Fund of Beneficial Interest

WDI

Western Asset Diversified Income Fund of Beneficial Interest

HOLD

Current Price

$13.62

Market Cap

715.3M

Sector

Finance

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$13.13

Market Cap

741.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDI
ZVRA
Founded
2021
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
715.3M
741.9M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
WDI
ZVRA
Price
$13.62
$13.13
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$23.00
AVG Volume (30 Days)
175.9K
1.5M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
11.80%
N/A
EPS Growth
N/A
159.21
EPS
1.12
0.60
Revenue
N/A
$106,470,000.00
Revenue This Year
N/A
$37.27
Revenue Next Year
N/A
$53.42
P/E Ratio
$12.20
$22.17
Revenue Growth
N/A
350.91
52 Week Low
$12.91
$7.16
52 Week High
$15.28
$15.04

Technical Indicators

Market Signals
Indicator
WDI
ZVRA
Relative Strength Index (RSI) 52.82 50.90
Support Level $13.60 $8.26
Resistance Level $13.79 $14.27
Average True Range (ATR) 0.18 0.68
MACD 0.02 -0.12
Stochastic Oscillator 59.26 21.71

Price Performance

Historical Comparison
WDI
ZVRA

About WDI Western Asset Diversified Income Fund of Beneficial Interest

Western Asset Diversified Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income. As a secondary investment objective, the Fund will seek capital appreciation. The fund seeks to achieve its investment objectives by investing, under normal market conditions, across fixed income sectors and securities in seeking to deliver a well-diversified portfolio.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: